Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder
- PMID: 9024275
- DOI: 10.1210/jcem.82.2.3765
Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder
Abstract
Renal phosphate-wasting disorders are the most common form of hereditary rickets and osteomalacia in western countries. Although autosomal dominant transmission of renal phosphate wasting has been described, previous studies included too few affected individuals to adequately characterize the disorder. We performed clinical and biochemical evaluations of individuals from a large kindred with autosomal dominant hypophosphatemic rickets/osteomalacia. We identified 23 affected members in this family, and for some individuals, follow-up was up to 25 yr. As patients were all members of the same kindred, we had the opportunity to determine the clinical manifestations of the disorder in patients who presumably all have the same genetic mutation. Affected individuals have isolated renal phosphate wasting and inappropriately normal serum calcitriol concentrations. The inheritance pattern was consistent with autosomal dominant transmission with variable penetrance. The family contained two subgroups of affected individuals. Group 1 consisted of patients who presented with renal phosphate wasting as adolescents or adults. These patients presented with bone pain, weakness, and insufficiency fractures, but did not manifest lower extremity deformity. Group 2 consisted of patients who presented with phosphate wasting, rickets, and lower extremity deformity as children. Surprisingly, some individuals in group 2 lost the renal phosphate-wasting defect after puberty. In conclusion, autosomal dominant hypophosphatemic rickets/osteomalacia is an inherited disorder of isolated renal phosphate wasting. The spectrum of disease includes delayed onset of penetrance and loss of the renal phosphate-wasting defect. Our results have implications in the evaluation of patients who present with renal phosphate wasting as either adults or children.
Similar articles
-
A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets.J Clin Endocrinol Metab. 1998 Oct;83(10):3459-62. doi: 10.1210/jcem.83.10.5167. J Clin Endocrinol Metab. 1998. PMID: 9768646
-
[Different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation in one family].Medicina (B Aires). 2004;64(2):103-6. Medicina (B Aires). 2004. PMID: 15628294 Spanish.
-
Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.J Clin Invest. 1980 Nov;66(5):1020-32. doi: 10.1172/JCI109930. J Clin Invest. 1980. PMID: 6253520 Free PMC article.
-
New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia.Curr Opin Nephrol Hypertens. 2002 Sep;11(5):547-53. doi: 10.1097/00041552-200209000-00011. Curr Opin Nephrol Hypertens. 2002. PMID: 12187320 Review.
-
Hypophosphatemic rickets and osteomalacia.Arq Bras Endocrinol Metabol. 2006 Aug;50(4):802-13. doi: 10.1590/s0004-27302006000400025. Arq Bras Endocrinol Metabol. 2006. PMID: 17117305 Review.
Cited by
-
Hypophosphatemia and growth.Pediatr Nephrol. 2013 Apr;28(4):595-603. doi: 10.1007/s00467-012-2364-9. Epub 2012 Nov 22. Pediatr Nephrol. 2013. PMID: 23179196 Review.
-
Iron deficiency plays essential roles in the trigger, treatment, and prognosis of autosomal dominant hypophosphatemic rickets.Osteoporos Int. 2021 Apr;32(4):737-745. doi: 10.1007/s00198-020-05649-w. Epub 2020 Sep 30. Osteoporos Int. 2021. PMID: 32995940
-
Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice.J Bone Miner Res. 2014 Feb;29(2):361-9. doi: 10.1002/jbmr.2049. J Bone Miner Res. 2014. PMID: 23873717 Free PMC article.
-
Approach to the hypophosphatemic patient.J Clin Endocrinol Metab. 2012 Mar;97(3):696-706. doi: 10.1210/jc.2011-1319. J Clin Endocrinol Metab. 2012. PMID: 22392950 Free PMC article.
-
FGF23 and Phosphate Wasting Disorders.Bone Res. 2013 Jun 28;1(2):120-32. doi: 10.4248/BR201302002. eCollection 2013 Jun. Bone Res. 2013. PMID: 26273497 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials